Status:
COMPLETED
Comparing Two Training Methods for Opioid Wizard
Lead Sponsor:
HealthPartners Institute
Collaborating Sponsors:
Hennepin Healthcare Research Institute
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-use Disorder
Opioid Dependence
Eligibility:
All Genders
Phase:
NA
Brief Summary
The prevalence of opioid use disorder (OUD) and opioid-related deaths has risen dramatically in recent years. Effective treatments, including medications for opioid use disorder (MOUDs; e.g., buprenor...
Detailed Description
Primary care offers an ideal setting in which to treat OUD; however, few clinicians are waivered to prescribe buprenorphine and of those who are waivered, less than one-third do prescribe. One potenti...
Eligibility Criteria
Inclusion
- Primary Care Clinician: Had to be a family physician, general internist, adult-care non-obstetric nurse practitioner, or a physician assistant
- Had to practice at a study-eligible primary care clinic already involved in the main study intervention arm
Exclusion
- PCCs were ineligible to participate if they had fewer than 5 eligible patient encounters between Sep 2020 and Feb 2021.
Key Trial Info
Start Date :
April 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04867382
Start Date
April 9 2021
End Date
November 30 2021
Last Update
December 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HealthPartners
Bloomington, Minnesota, United States, 55425-4516